Cyndeo Wealth Partners’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
Cyndeo Wealth Partners's CPRX Position: Q3 2026 in Review
Cyndeo Wealth Partners sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 118,444 shares — an estimated $3.72M sold.
Cyndeo Wealth Partners first reported a position in CPRX in Q4 2022 and held it in 15 quarters. The position peaked at $3.72M in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Cyndeo Wealth Partners reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Cyndeo Wealth Partners sold 118,444 Catalyst Pharmaceutical shares in Q3 2026, an estimated $3.72M.
- Cyndeo Wealth Partners first reported a position in Catalyst Pharmaceutical in Q4 2022 and held it in 15 quarters.
- Cyndeo Wealth Partners's Catalyst Pharmaceutical position peaked at $3.72M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Cyndeo Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.